Biogen - 27 Year Stock Price History | BIIB

Historical daily share price chart and data for Biogen since 1991 adjusted for splits and dividends. Open, high, low, close (OHLC) data as well as percentage changes for multiple date ranges. Display 20, 50 and 200 day moving averages and export charts as images to use in articles and blogs. The latest closing price for Biogen as of November 15, 2018 is 321.72.
Biogen Historical Annual Stock Price Data
Year Average Stock Price Year Open Year High Year Low Year Close Annual % Change
2018 313.7820 334.1700 383.8300 257.5200 321.7200 0.99%
2017 289.1924 268.8803 344.5800 246.5400 318.5700 21.88%
2016 258.2701 271.5625 304.2750 207.0224 261.3865 -7.43%
2015 324.9891 315.2437 438.7290 236.0019 282.3745 -9.75%
2014 293.0971 258.3909 332.4433 252.1115 312.8840 21.42%
2013 198.4327 138.2607 272.7239 131.6427 257.6922 91.00%
2012 125.8311 104.6173 143.8465 104.6173 134.9148 33.00%
2011 84.7777 61.9408 109.4288 59.9867 101.4373 64.13%
2010 51.9472 49.4420 62.8810 42.6027 61.8025 25.33%
2009 45.1133 44.6951 49.4973 38.8328 49.3130 12.32%
2008 51.0893 51.4975 65.7937 35.9662 43.9024 -16.32%
2007 52.1588 45.4693 76.0526 39.7546 52.4653 15.71%
2006 42.3905 43.0820 48.1700 37.5424 45.3403 8.64%
2005 39.8850 61.1020 62.4939 30.7400 41.7363 -32.02%
2004 52.7677 34.0490 62.6045 34.0490 61.3970 81.50%
2003 31.7365 31.6525 38.3167 25.8916 33.8278 10.64%
2002 43.7536 62.8165 65.4065 27.7904 30.5741 -51.88%
2001 52.5351 54.6130 68.7340 32.8968 63.5354 9.09%
2000 40.8053 28.6507 69.2072 17.6298 58.2416 92.94%
1999 12.9850 7.1819 30.1869 6.3185 30.1869 318.08%
1998 5.0456 5.2032 7.3923 2.6884 7.2203 36.71%
1997 4.3215 3.4565 7.0667 2.4964 5.2816 44.76%
1996 3.4365 2.9373 4.6271 2.2460 3.6485 21.80%
1995 1.0523 0.3641 3.5533 0.3457 2.9956 815.53%
1994 0.5396 0.8634 0.9985 0.3272 0.3272 -62.96%
1993 0.8822 1.3826 1.3826 0.5761 0.8833 -34.29%
1992 1.5007 1.9587 3.0725 0.9601 1.3442 -32.69%
Sector Industry Market Cap Revenue
Medical Medical - Biomedical and Genetics $64.289B $12.274B
Biogen is a leading biopharmaceutical company engaged in the research, development and marketing of targeted therapies for the treatment of cancer, autoimmune and inflammatory diseases. The company owns industry leading brands for the treatment of multiple sclerosis, next-generation treatments for hemophilia, and a deep clinical pipeline ranging from Alzheimer's disease, lupus nephritis to neuropathic pain.
Stock Name Country Market Cap PE Ratio
Amgen (AMGN) United States $122.059B 13.80
Gilead Sciences (GILD) United States $91.744B 11.05
Celgene (CELG) United States $49.115B 9.53
Illumina (ILMN) United States $45.743B 53.28
Vertex Pharmaceuticals (VRTX) United States $43.524B 76.03
Regeneron Pharmaceuticals (REGN) United States $36.966B 18.75
Alexion Pharmaceuticals (ALXN) United States $26.441B 18.09
BioMarin Pharmaceutical (BMRN) United States $16.652B 0.00
Incyte (INCY) United States $13.562B 374.88
Seattle Genetics (SGEN) United States $8.782B 0.00
Exact Sciences (EXAS) United States $8.531B 0.00
Bio-Rad Laboratories (BIO.B) United States $8.015B 51.25
QIAGEN (QGEN) Netherlands $7.959B 25.45
Sarepta Therapeutics (SRPT) United States $7.803B 0.00
Alnylam Pharmaceuticals (ALNY) United States $6.800B 0.00
Bluebird Bio (BLUE) United States $6.579B 0.00
BeiGene (BGNE) Cayman Islands $6.166B 0.00
Bio-Techne Corp (TECH) United States $6.117B 41.32
Galapagos (GLPG) Belgium $5.266B 0.00
Alkermes (ALKS) Ireland $5.263B 3387.00
Exelixis (EXEL) United States $4.978B 14.11
Amarin (AMRN) Ireland $4.496B 0.00
Horizon Pharma Public (HZNP) Ireland $3.663B 15.07
Immunomedics (IMMU) United States $3.576B 0.00
MorphoSys AG Unsponsored ADR (MOR) Germany $3.569B 0.00
Emergent Biosolutions (EBS) United States $3.400B 28.64
Allogene Therapeutics (ALLO) United States $3.192B 0.00
Ligand Pharmaceuticals (LGND) United States $3.155B 24.14
Guardant Health (GH) United States $3.148B 0.00
Array BioPharma (ARRY) United States $3.134B 0.00
Intercept Pharmaceuticals (ICPT) United States $2.987B 0.00
ARGENX SE-ADR (ARGX) Netherlands $2.974B 0.00
Repligen (RGEN) United States $2.868B 89.57
Genomic Health (GHDX) United States $2.814B 95.00
Blueprint Medicines (BPMC) United States $2.642B 0.00
Ascendis Pharma (ASND) Denmark $2.564B 0.00
Ultragenyx Pharmaceutical (RARE) United States $2.471B 0.00
China Biologic Products (CBPO) China $2.418B 17.22
Allakos (ALLK) United States $2.399B 0.00
Acceleron Pharma (XLRN) United States $2.372B 0.00
Akcea Therapeutics (AKCA) United States $2.333B 0.00
MyoKardia (MYOK) United States $2.279B 0.00
REGENXBIO (RGNX) United States $2.247B 30.14
Myriad Genetics (MYGN) United States $2.242B 22.22
Halozyme Therapeutics (HALO) United States $2.238B 49.94
ACADIA Pharmaceuticals (ACAD) United States $2.228B 0.00
Amicus Therapeutics (FOLD) United States $2.041B 0.00
Global Blood Therapeutics (GBT) United States $1.973B 0.00
CRISPR Therapeutics AG (CRSP) Switzerland $1.893B 0.00
AnaptysBio (ANAB) United States $1.870B 0.00
Reata Pharmaceuticals (RETA) United States $1.823B 0.00
Medicines (MDCO) United States $1.684B 0.00
Aimmune Therapeutics (AIMT) United States $1.666B 0.00
Arena Pharmaceuticals (ARNA) United States $1.662B 0.00
Denali Therapeutics (DNLI) United States $1.640B 0.00
Innoviva (INVA) United States $1.636B 9.25
G1 THERAPEUTICS (GTHX) United States $1.618B 0.00
Spark Therapeutics (ONCE) United States $1.611B 0.00
Atara Biotherapeutics (ATRA) United States $1.587B 0.00
Cambrex (CBM) United States $1.580B 11.80
NeoGenomics (NEO) United States $1.535B 126.92
Autolus Therapeutics Sponsored ADR (AUTL) United Kingdom $1.532B 0.00
Biohaven Pharmaceutical Holding (BHVN) United States $1.481B 0.00
Rubius Therapeutics (RUBY) United States $1.390B 0.00
Editas Medicine (EDIT) United States $1.386B 0.00
Nabriva Therapeutics AG (NBRV) Ireland $1.356B 0.00
IMMURON LTD (IMRN) Australia $1.294B 0.00
Myovant Sciences (MYOV) United Kingdom $1.277B 0.00
Insmed (INSM) United States $1.233B 0.00
ORCHARD THERAPT (ORTX) United Kingdom $1.223B 0.00
Mirati Therapeutics (MRTX) United States $1.210B 0.00
Vanda Pharmaceuticals (VNDA) United States $1.184B 94.04
WAVE Life Sciences (WVE) Singapore $1.151B 0.00
Solid Biosciences (SLDB) United States $1.132B 0.00
Sangamo Therapeutics (SGMO) United States $1.103B 0.00
Cellectis (CLLS) France $1.071B 0.00
Momenta Pharmaceuticals (MNTA) United States $1.004B 0.00
Audentes Therapeutics (BOLD) United States $1.003B 0.00
Retrophin (RTRX) United States $0.999B 0.00
Zai Lab Unsponsored ADR (ZLAB) China $0.984B 0.00
Rhythm Pharmaceuticals (RYTM) United States $0.979B 0.00
Intra-Cellular Therapies (ITCI) United States $0.947B 0.00
DBV Technologies (DBVT) France $0.943B 0.00
Acorda Therapeutics (ACOR) United States $0.918B 11.63
Alder BioPharmaceuticals (ALDR) United States $0.901B 0.00
UniQure (QURE) Netherlands $0.892B 0.00
Lexicon Pharmaceuticals (LXRX) United States $0.891B 0.00
Lion Biotechnologies (IOVA) United States $0.877B 0.00
Dicerna Pharmaceuticals (DRNA) United States $0.860B 0.00
Apellis Pharmaceuticals (APLS) United States $0.856B 0.00
Aptinyx (APTX) United States $0.854B 0.00
Fate Therapeutics (FATE) United States $0.844B 0.00
Puma Biotechnology (PBYI) United States $0.841B 0.00
Viking Therapeutics (VKTX) United States $0.824B 0.00
Deciphera Pharmaceuticals (DCPH) United States $0.815B 0.00
Clovis Oncology (CLVS) United States $0.804B 0.00
Kiniksa Pharmaceuticals (KNSA) Bermuda $0.804B 0.00
Revance Therapeutics (RVNC) United States $0.803B 0.00
Intellia Therapeutics (NTLA) United States $0.793B 0.00
Athenex (ATNX) United States $0.779B 0.00
Coherus BioSciences (CHRS) United States $0.758B 0.00
Cara Therapeutics (CARA) United States $0.743B 0.00
Heska (HSKA) United States $0.742B 60.72
Dynavax Technologies (DVAX) United States $0.739B 0.00
ProQR Therapeutics (PRQR) Netherlands $0.723B 0.00
InflaRx (IFRX) Germany $0.720B 0.00
AVROBIO (AVRO) United States $0.717B 0.00
Vericel (VCEL) United States $0.713B 0.00
TWIST BIOSCIENC (TWST) United States $0.649B 0.00
Novavax (NVAX) United States $0.647B 0.00
UROGEN PHARMA (URGN) Israel $0.646B 0.00
CytomX Therapeutics (CTMX) United States $0.642B 0.00
ANI Pharmaceuticals (ANIP) United States $0.612B 11.73
Gritstone Oncology (GRTS) United States $0.601B 0.00
Epizyme (EPZM) United States $0.600B 0.00
AMAG Pharmaceuticals (AMAG) United States $0.596B 0.00
AC Immune SA (ACIU) Switzerland $0.588B 0.00
Inotek Pharmaceuticals (RCKT) United States $0.587B 0.00
Principia Biopharma (PRNB) United States $0.575B 0.00
Adaptimmune Therapeutics (ADAP) United Kingdom $0.567B 0.00
Senesco Technologies (ELOX) United States $0.561B 0.00
NuCana Sponsored ADR (NCNA) United Kingdom $0.560B 0.00
Scholar Rock Holding (SRRK) United States $0.556B 0.00
Arvinas (ARVN) United States $0.549B 0.00
UNITY Biotechnology (UBX) $0.531B 0.00
ObsEva SA (OBSV) Switzerland $0.514B 0.00
Eidos Therapeutics (EIDX) United States $0.510B 0.00
Anika Therapeutics (ANIK) United States $0.509B 21.07
Arcus Biosciences (RCUS) United States $0.495B 0.00
Mesoblast (MESO) Australia $0.480B 0.00
Kezar Life Sciences (KZR) United States $0.478B 0.00
BeyondSpring (BYSI) United States $0.464B 0.00
Inovio Pharmaceuticals (INO) United States $0.461B 0.00
Clementia Pharmaceuticals (CMTA) Canada $0.460B 0.00
Prothena (PRTA) Ireland $0.456B 0.00
Kura Oncology (KURA) United States $0.441B 0.00
Sorrento Therapeutics (SRNE) United States $0.435B 71.20
Replimune (REPL) United States $0.432B 0.00
Sinovac Biotech (SVA) China $0.429B 0.00
MediciNova (MNOV) United States $0.426B 0.00
Kindred Biosciences (KIN) United States $0.424B 0.00
PDL BioPharma (PDLI) United States $0.422B 6.88
Zymeworks (ZYME) Canada $0.417B 0.00
Five Prime Therapeutics (FPRX) United States $0.399B 0.00
RA PHARMCTL INC (RARX) United States $0.397B 0.00
ZIOPHARM Oncology Inc (ZIOP) United States $0.384B 0.00
Achillion Pharmaceuticals (ACHN) United States $0.374B 0.00
Zealand Pharma (ZEAL) Denmark $0.374B 0.00
Verastem (VSTM) United States $0.373B 0.00
Stemline Therapeutics (STML) United States $0.372B 0.00
Osiris Therapeutics (OSIR) United States $0.369B 0.00
Abeona Therapeutics (ABEO) United States $0.368B 0.00
Nightstar Therapeutics Sponsored ADR (NITE) United States $0.366B 0.00
Cytokineticsorporated (CYTK) United States $0.356B 0.00
MeiraGTx Holdings (MGTX) United States $0.344B 0.00
Seres Therapeutics (MCRB) United States $0.331B 0.00
Cellular Biomedicine (CBMG) United States $0.324B 0.00
Merus (MRUS) Netherlands $0.315B 0.00
ResTORbio (TORC) United States $0.310B 0.00
LogicBio Therapeutics (LOGC) United States $0.305B 0.00
Sutro Biopharma (STRO) United States $0.304B 0.00
Liquidia Technologies (LQDA) United States $0.299B 0.00
Albireo Pharma (ALBO) United States $0.299B 0.00
Kodiak Sciences (KOD) United States $0.298B 0.00
Keryx Biopharmaceuticals (KERX) United States $0.297B 0.00
Krystal Biotech (KRYS) United States $0.295B 0.00
Geron (GERN) United States $0.291B 0.00
MannKind (MNKD) United States $0.290B 0.00
Kadmon Holdings (KDMN) United States $0.287B 0.00
Celcuity (CELC) United States $0.284B 0.00
Biofrontera AG Sponsored ADR (BFRA) Germany $0.284B 0.00
Peregrine Pharmaceuticals (CDMO) United States $0.277B 0.00
Celyad SA (CYAD) Belgium $0.265B 0.00
Athersys (ATHX) United States $0.265B 0.00
Arbutus Biopharma (ABUS) Canada $0.265B 0.00
Syros Pharmaceuticals (SYRS) United States $0.262B 0.00
Equillium (EQ) United States $0.260B 0.00
BioDelivery Sciences (BDSI) United States $0.256B 0.00
Aduro Biotech (ADRO) United States $0.254B 0.00
Evelo Biosciences (EVLO) United States $0.246B 0.00
Strongbridge Biopharma (SBBP) United States $0.244B 0.00
TOCAGEN INC (TOCA) United States $0.243B 0.00
Agenus (AGEN) United States $0.239B 0.00
Axovant Sciences (AXON) United Kingdom $0.238B 0.00
ADMA Biologics Inc (ADMA) United States $0.237B 0.00
GAMIDA CELL LTD (GMDA) Israel $0.234B 0.00
Unum Therapeutics (UMRX) United States $0.234B 0.00
AVEO Pharmaceuticals (AVEO) United States $0.233B 0.00
Proteostasis Therapeutics (PTI) United States $0.231B 0.00
Adverum Biotechnologies (ADVM) United States $0.228B 0.00
Magenta Therapeutics (MGTA) United States $0.228B 0.00
Urovant Sciences (UROV) United States $0.222B 0.00
Kala Pharmaceuticals (KALA) United States $0.222B 0.00
BioTime (BTX) United States $0.221B 0.00
Paratek Pharmaceuticals (PRTK) United States $0.220B 0.00
Kamada (KMDA) Israel $0.219B 20.15
Corvus Pharmaceuticals (CRVS) United States $0.212B 0.00
Idera Pharmaceuticals (IDRA) United States $0.207B 0.00
Sienna Biopharmaceuticals (SNNA) United States $0.205B 0.00
Protagonist Therapeutics (PTGX) United States $0.202B 0.00
Synlogic (SYBX) United States $0.195B 0.00
Intec Pharma (NTEC) Israel $0.194B 0.00
Aeglea BioTherapeutics (AGLE) United States $0.189B 0.00
ChromaDex (CDXC) United States $0.188B 0.00
NantKwest (NK) United States $0.188B 0.00
Allena Pharmaceuticals (ALNA) United States $0.174B 0.00
Pieris Pharmaceuticals (PIRS) United States $0.172B 0.00
ASLAN Pharmaceuticals (ASLN) Singapore $0.170B 0.00
Spring Bank Pharmaceuticals (SBPH) United States $0.167B 0.00
Palatin Technologies (PTN) United States $0.165B 20.30
Compugen (CGEN) Israel $0.164B 0.00
Xenon Pharmaceuticals (XENE) Canada $0.162B 0.00
Cerecor (CERC) United States $0.157B 0.00
Cohbar (CWBR) United States $0.156B 0.00
Menlo Therapeutics (MNLO) United States $0.156B 0.00
Spero Therapeutics (SPRO) United States $0.154B 0.00
Pfenex (PFNX) United States $0.153B 0.00
Enzo Biochem (ENZ) United States $0.151B 0.00
PSivida (EYPT) United States $0.151B 0.00
Constellation Pharmaceuticals (CNST) United States $0.148B 0.00
Verona Pharma American Depositary Share (VRNA) United Kingdom $0.145B 0.00
XBiotech (XBIT) United States $0.143B 0.00
Erytech Pharma SA Sponsored ADR (ERYP) France $0.141B 0.00
Mersana Therapeutics (MRSN) United States $0.140B 0.00
Eiger BioPharmaceuticals (EIGR) United States $0.138B 0.00
Pluristem Therapeutics (PSTI) Israel $0.135B 0.00
Eleven Biotherapeutics (SESN) United States $0.131B 0.00
Organovo Holdings (ONVO) United States $0.130B 0.00
Applied Genetic Technologies (AGTC) United States $0.130B 0.00
Syndax Pharmaceuticals (SNDX) United States $0.129B 0.00
OVID THERAPEUTC (OVID) United States $0.127B 0.00
Selecta Biosciences (SELB) United States $0.127B 0.00
Catalyst Biosciences (CBIO) United States $0.125B 0.00
VBI Vaccines (VBIV) United States $0.123B 0.00
Cue Biopharma (CUE) United States $0.122B 0.00
Mustang Bio (MBIO) United States $0.120B 0.00
Signal Genetics (MGEN) United States $0.112B 0.00
Nymox Pharmaceutical (NYMX) Canada $0.112B 0.00
XOMA (XOMA) United States $0.111B 0.00
Anavex Life Sciences (AVXL) United States $0.111B 0.00
CorMedix Inc (CRMD) United States $0.111B 0.00
Motif Bio Plc (MTFB) United States $0.110B 0.00
Cidara Therapeutics (CDTX) United States $0.108B 0.00
Provention Bio (PRVB) United States $0.102B 0.00
Aridis Pharmaceuticals (ARDS) United States $0.099B 0.00
PHASEBIO PHARMA (PHAS) United States $0.097B 0.00
Chiasma (CHMA) United States $0.097B 0.00
ScPharmaceuticals (SCPH) United States $0.095B 0.00
Orgenesis (ORGS) United States $0.091B 0.00
Monster Digital (INNT) United States $0.089B 0.00
Neothetics (EVFM) United States $0.088B 0.00
BioXcel Therapeutics (BTAI) United States $0.087B 0.00
Axsome Therapeutics (AXSM) United States $0.086B 0.00
Ophthotech (OPHT) United States $0.084B 0.00
VolitionRX (VNRX) Singapore $0.081B 0.00
Aerpio Pharmaceuticals (ARPO) United States $0.081B 0.00
Cocrystal Pharma (COCP) United States $0.081B 90.00
Cel-Sci (CVM) United States $0.076B 0.00
Checkpoint Therapeutics (CKPT) United States $0.076B 0.00
Aptose Biosciences (APTO) Canada $0.076B 0.00
Vaccinex (VCNX) United States $0.075B 0.00
Prima BioMed (IMMP) Australia $0.074B 0.00
Alcobra (ARCT) United States $0.074B 0.00
Aptevo Therapeutics (APVO) United States $0.073B 0.00
VTv Therapeutics (VTVT) United States $0.072B 0.00
Alimera Sciences (ALIM) United States $0.071B 0.00
NewLink Genetics (NLNK) United States $0.071B 0.00
Evogene (EVGN) Israel $0.070B 0.00
Bionano Genomics (BNGO) United States $0.070B 0.00
ITUS (ANIX) United States $0.069B 0.00
Asterias Biotherapeutics (AST) United States $0.069B 0.00
Brainstorm Cell Therapeutics (BCLI) United States $0.064B 0.00
Fortress Biotech (FBIO) United States $0.063B 0.00
Merrimack Pharmaceuticals (MACK) United States $0.061B 0.00
VistaGen Therapeutics (VTGN) United States $0.060B 0.00
Protalix BioTherapeutics (PLX) Israel $0.060B 0.00
Sophiris Bio (SPHS) United States $0.060B 0.00
Entera Bio (ENTX) Israel $0.060B 0.00
Celldex Therapeutics (CLDX) United States $0.059B 0.00
Bellerophon Therapeutics (BLPH) United States $0.058B 0.00
OncoMed Pharmaceuticals (OMED) United States $0.058B 9.38
Oncobiologics (ONS) United States $0.058B 0.00
Leap Therapeutics (LPTX) United States $0.057B 0.00
Trevena (TRVN) United States $0.055B 0.00
Clearside Biomedical (CLSD) United States $0.051B 0.00
OncoSec Medical (ONCS) United States $0.050B 0.00
Curis (CRIS) United States $0.049B 0.00
Sunesis Pharmaceuticals (SNSS) United States $0.049B 0.00
Caladrius Biosciences (CLBS) United States $0.048B 0.00
Catabasis Pharmaceuticals (CATB) United States $0.047B 0.00
Zosano Pharma (ZSAN) United States $0.046B 0.00
Vascular Biogenics (VBLT) Israel $0.044B 0.00
TRACON Pharmaceuticals (TCON) United States $0.042B 0.00
Rexahn Pharmaceuticals (RNN) United States $0.042B 0.00
Oncolytics Biotech (ONCY) Canada $0.041B 0.00
AZURRX BIOPHARM (AZRX) United States $0.039B 0.00
BiondVax Pharmaceuticals (BVXV) Israel $0.039B 0.00
AEterna Zentaris (AEZS) United States $0.039B 7.44
Versartis (ARAV) United States $0.039B 6.29
AquaBounty Technologies (AQB) United States $0.039B 0.00
Celsion (CLSN) United States $0.039B 0.00
Galena Biopharma (SLS) United States $0.038B 0.00
Moleculin Biotech (MBRX) United States $0.037B 0.00
VIVUS (VVUS) United States $0.035B 0.00
GTx (GTXI) United States $0.035B 0.00
BioPharmX (BPMX) United States $0.034B 0.00
Aileron Therapeutics (ALRN) United States $0.032B 0.00
Proteon Therapeutics (PRTO) United States $0.032B 0.00
Therapix Biosciences (TRPX) Israel $0.029B 10.61
Vical (VICL) United States $0.028B 0.00
Advaxis (ADXS) United States $0.027B 0.00
Eyenovia (EYEN) United States $0.026B 0.00
OvaScience (OVAS) United States $0.025B 0.00
Benitec Biopharma (BNTC) Australia $0.025B 0.00
Cellect Biotechnology (APOP) Israel $0.024B 0.00
CytRx (CYTR) United States $0.023B 0.00
Novelion Therapeutics (NVLN) Canada $0.022B 0.00
Akari Therapeutics (AKTX) United Kingdom $0.021B 0.00
GENPREX INC (GNPX) United States $0.021B 0.00
Edge Therapeutics (EDGE) United States $0.021B 0.00
Pulmatrix (PULM) United States $0.020B 0.00
Genetic Technologies (GENE) Australia $0.019B 0.00
Cleveland BioLabs (CBLI) United States $0.019B 0.00
Fibrocell Science Inc (FCSC) United States $0.019B 0.00
TrovaGene (TROV) United States $0.018B 0.00
Soligenix (SNGX) United States $0.018B 0.00
Arsanis (ASNS) United States $0.018B 0.00
Gemphire Therapeutics (GEMP) United States $0.017B 0.00
RestorGenex (DFFN) United States $0.017B 0.00
ATyr Pharma (LIFE) United States $0.016B 0.00
Prana Biotechnology (PRAN) Australia $0.015B 0.00
Cyclacel Pharmaceuticals (CYCC) United States $0.014B 0.00
IBio (IBIO) United States $0.014B 0.00
Vital Therapies (VTL) United States $0.014B 0.00
Novogen (KZIA) Australia $0.013B 0.00
Histogenics (HSGX) United States $0.013B 0.00
Oragenics (OGEN) United States $0.011B 0.00
Cerulean Pharma (DARE) United States $0.011B 0.00
Hemispherx BioPharma (HEB) United States $0.010B 0.00
ARCA Biopharma (ABIO) United States $0.010B 0.00
AmpliPhi Biosciences (APHB) United States $0.010B 0.00
Titan Pharmaceuticals (TTNP) United States $0.009B 0.00
Alliqua BioMedical (ALQA) United States $0.009B 0.00
Flex Pharma (FLKS) United States $0.009B 0.00
MYOS RENS Technology (MYOS) United States $0.008B 0.00
Adial Pharmaceuticals (ADIL) United States $0.008B 0.00
Neuralstem (CUR) United States $0.008B 0.00
ContraVir Pharmaceuticals Inc (CTRV) United States $0.007B 0.00
Synthetic Biologics (SYN) United States $0.006B 0.00
Tenax Therapeutics (TENX) United States $0.006B 0.00
Stellar Biotechnologies (SBOT) United States $0.006B 0.00
Cytori Therapeutics Inc (CYTX) United States $0.003B 0.00
Aytu Bioscience (AYTU) United States $0.002B 0.00
OSMOTICA PHARM (OSMT) United States $0.000B 0.00
Y-mAbs Therapeutics (YMAB) United States $0.000B 0.00